CN1492929A - 肌细胞分化因子Fwa267 - Google Patents
肌细胞分化因子Fwa267 Download PDFInfo
- Publication number
- CN1492929A CN1492929A CNA028055098A CN02805509A CN1492929A CN 1492929 A CN1492929 A CN 1492929A CN A028055098 A CNA028055098 A CN A028055098A CN 02805509 A CN02805509 A CN 02805509A CN 1492929 A CN1492929 A CN 1492929A
- Authority
- CN
- China
- Prior art keywords
- polypeptide
- polynucleotides
- fwa267
- dna
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Cardiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
本发明公开了肌细胞分化因子Fwa267多肽和编码这种多肽的多核苷酸。本发明也公开了用重组技术生产Fwa267多肽的方法和针对这种多肽的抗体和拮抗剂。本发明还公开了含有Fwa267多肽的药物组合物以及Fwa267在治疗心血管增生性疾病、抑制肿瘤形成等方面的用途。本发明还提供了通过检测样品中Fwa267核酸序列中的突变,或者Fwa267多肽含量及Fwa267基因产物自身抗体水平的改变而进行诊断和测定的方法。本发明的肌细胞分化因子是人类来源的。
Description
PCT国内申请,说明书已公开。
Claims (1)
- PCT国内申请,权利要求书已公开。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN01109260A CN1373216A (zh) | 2001-02-28 | 2001-02-28 | 肌细胞增殖抑制因子Fwa267 |
CN01109260.2 | 2001-02-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1492929A true CN1492929A (zh) | 2004-04-28 |
Family
ID=4657824
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN01109260A Pending CN1373216A (zh) | 2001-02-28 | 2001-02-28 | 肌细胞增殖抑制因子Fwa267 |
CNA028055098A Pending CN1492929A (zh) | 2001-02-28 | 2002-02-28 | 肌细胞分化因子Fwa267 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN01109260A Pending CN1373216A (zh) | 2001-02-28 | 2001-02-28 | 肌细胞增殖抑制因子Fwa267 |
Country Status (3)
Country | Link |
---|---|
US (1) | US20040110683A1 (zh) |
CN (2) | CN1373216A (zh) |
WO (1) | WO2002068640A1 (zh) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2173592C (en) * | 1993-10-06 | 2007-09-25 | Michael J. P. Lawman | Stem cell proliferation factor |
US6432673B1 (en) * | 1998-12-07 | 2002-08-13 | Zymogenetics, Inc. | Growth factor homolog ZVEGF3 |
CN1326973A (zh) * | 2000-06-07 | 2001-12-19 | 上海博德基因开发有限公司 | 一种新的多肽——人层粘连蛋白γ3链(LAMC3)69.85和编码这种多肽的多核苷酸 |
-
2001
- 2001-02-28 CN CN01109260A patent/CN1373216A/zh active Pending
-
2002
- 2002-02-28 CN CNA028055098A patent/CN1492929A/zh active Pending
- 2002-02-28 WO PCT/CN2002/000126 patent/WO2002068640A1/zh not_active Application Discontinuation
-
2003
- 2003-08-28 US US10/650,284 patent/US20040110683A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20040110683A1 (en) | 2004-06-10 |
WO2002068640A1 (fr) | 2002-09-06 |
CN1373216A (zh) | 2002-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2002521055A (ja) | 98個のヒト分泌タンパク質 | |
JP2002533058A (ja) | 97個のヒト分泌タンパク質 | |
JP2003514541A (ja) | 18個のヒト分泌タンパク質 | |
JP2003528587A (ja) | 27個のヒト分泌タンパク質 | |
JP2002501738A (ja) | 67個のヒト分泌タンパク質 | |
JP2003513662A (ja) | 15個のヒト分泌タンパク質 | |
JP2002526059A (ja) | 31個のヒト分泌タンパク質 | |
JP2008167759A (ja) | ステロイド抵抗性ネフローゼ症候群に関与するnphs2遺伝子、上記遺伝子によりコードされるタンパク質、並びにそれらの診断的及び治療的使用 | |
JP2003524366A (ja) | 64個のヒト分泌タンパク質 | |
JPH11509093A (ja) | 乳房特異的遺伝子およびタンパク質 | |
JP2003501026A (ja) | 脂質代謝転写因子 | |
JP2002505871A (ja) | 31個のヒト分泌タンパク質 | |
JP2002514925A (ja) | 19個のヒト分泌タンパク質 | |
JPH11506920A (ja) | 結腸特異的遺伝子およびタンパク質 | |
JP2003514543A (ja) | 23個のヒト分泌タンパク質 | |
JP4476491B2 (ja) | 新規膜貫通蛋白質をコードする遺伝子 | |
JP2003521216A (ja) | 90個のヒト分泌タンパク質 | |
JP2003521215A (ja) | 83個のヒト分泌タンパク質 | |
JPH10513044A (ja) | ヒト前立腺特異的還元酵素 | |
CN1509332A (zh) | 炎性抑制因子Fwa116 | |
CN1492929A (zh) | 肌细胞分化因子Fwa267 | |
JP2000509255A (ja) | 感覚神経障害と関連した遺伝子ファミリー | |
JP2002530058A (ja) | 31個のヒト分泌タンパク質 | |
US20030054446A1 (en) | Novel retina-specific human proteins C7orf9, C12orf7, MPP4 and F379 | |
JP2003520030A (ja) | 28個のヒト分泌タンパク質 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |